Canoe Financial LP Invests $41,000 in HCA Healthcare, Inc. (NYSE:HCA)

Canoe Financial LP purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 102 shares of the company’s stock, valued at approximately $41,000.

A number of other hedge funds have also recently modified their holdings of the business. NorthRock Partners LLC lifted its position in shares of HCA Healthcare by 17.4% during the first quarter. NorthRock Partners LLC now owns 1,310 shares of the company’s stock valued at $437,000 after buying an additional 194 shares during the last quarter. Financial Strategies Group Inc. grew its position in shares of HCA Healthcare by 12.8% in the first quarter. Financial Strategies Group Inc. now owns 16,289 shares of the company’s stock valued at $5,357,000 after purchasing an additional 1,844 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH raised its holdings in shares of HCA Healthcare by 2,471.9% during the 1st quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 7,690 shares of the company’s stock worth $2,565,000 after acquiring an additional 7,391 shares during the period. Financial Security Advisor Inc. grew its stake in shares of HCA Healthcare by 6.0% in the 1st quarter. Financial Security Advisor Inc. now owns 7,530 shares of the company’s stock valued at $2,516,000 after buying an additional 427 shares during the period. Finally, Hedeker Wealth LLC raised its holdings in HCA Healthcare by 0.8% in the 1st quarter. Hedeker Wealth LLC now owns 11,117 shares of the company’s stock valued at $3,708,000 after buying an additional 89 shares during the period. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HCA. Morgan Stanley began coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Royal Bank of Canada lifted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. UBS Group upped their price objective on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Finally, Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, August 19th. Five analysts have rated the stock with a hold rating, twelve have given a buy rating and four have given a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $377.17.

Insider Buying and Selling

In related news, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $363.55 on Monday. The stock has a market capitalization of $95.22 billion, a price-to-earnings ratio of 18.12, a price-to-earnings-growth ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a fifty-two week low of $220.55 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The business’s fifty day moving average price is $395.06 and its two-hundred day moving average price is $352.71.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.73%. HCA Healthcare’s payout ratio is presently 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.